{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:27:42Z","timestamp":1789882062427,"version":"4.0.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T00:00:00Z","timestamp":1229385600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0003951","type":"journal-article","created":{"date-parts":[[2008,12,13]],"date-time":"2008-12-13T00:02:31Z","timestamp":1229126551000},"page":"e3951","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":64,"title":["Pyrvinium Targets the Unfolded Protein Response to Hypoglycemia and Its Anti-Tumor Activity Is Enhanced by Combination Therapy"],"prefix":"10.1371","volume":"3","author":[{"given":"De-Hua","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flossie","family":"Wong-Staal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,12,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0168-9525(93)90209-Z","article-title":"The multistep nature of cancer.","volume":"9","author":"B Vogelstein","year":"1993","journal-title":"Trends Genet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.4161\/cbt.5.7.2967","article-title":"The PERK\/eIF2alpha\/ATF4 module of the UPR in hypoxia resistance and tumor growth.","volume":"5","author":"DR Fels","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1158\/0008-5472.CAN-05-3092","article-title":"Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells.","volume":"66","author":"AC Ranganathan","year":"2006","journal-title":"Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1158\/0008-5472.CAN-04-1606","article-title":"XBP1 is essential for survival under hypoxic conditions and is required for tumor growth.","volume":"64","author":"L Romero-Ramirez","year":"2004","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4161\/cbt.5.7.2970","article-title":"Glucose regulated proteins in cancer progression, drug resistance and immunotherapy.","volume":"5","author":"Y Fu","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1158\/0008-5472.CAN-07-0325","article-title":"GRP78 induction in cancer: therapeutic and prognostic implications.","volume":"67","author":"AS Lee","year":"2007","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tcb.2003.11.001","article-title":"A trip to the ER: coping with stress.","volume":"14","author":"DT Rutkowski","year":"2004","journal-title":"Trends Cell Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1006332011207","article-title":"Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions.","volume":"59","author":"PM Fernandez","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1006102411439","article-title":"De-regulation of GRP stress protein expression in human breast cancer cell lines.","volume":"54","author":"G Gazit","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"ref10","first-page":"8322","article-title":"Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon\/ERK\/AP-1 signaling cascade.","volume":"61","author":"MS Song","year":"2001","journal-title":"Cancer Res"},{"key":"ref11","first-page":"4333","article-title":"Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas.","volume":"19","author":"R Koomagi","year":"1999","journal-title":"Anticancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0168-8278(03)00029-1","article-title":"Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis.","volume":"38","author":"M Shuda","year":"2003","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ccr.2004.08.018","article-title":"Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands.","volume":"6","author":"MA Arap","year":"2004","journal-title":"Cancer Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/sj.onc.1209139","article-title":"Celecoxib upregulates endoplasmic reticulum chaperones that inhibit celecoxib-induced apoptosis in human gastric cells.","volume":"25","author":"S Tsutsumi","year":"2006","journal-title":"Oncogene"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/jnci\/djh243","article-title":"Effect on tumor cells of blocking survival response to glucose deprivation.","volume":"96","author":"HR Park","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1349-7006.2004.tb03330.x","article-title":"Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-me thyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation.","volume":"95","author":"H Esumi","year":"2004","journal-title":"Cancer Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"20915","DOI":"10.1074\/jbc.M212328200","article-title":"Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation.","volume":"278","author":"RK Reddy","year":"2003","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1042\/bj20011802","article-title":"Requirement of the p38 mitogen-activated protein kinase signalling pathway for the induction of the 78 kDa glucose-regulated protein\/immunoglobulin heavy-chain binding protein by azetidine stress: activating transcription factor 6 as a target for stress-induced phosphorylation.","volume":"366","author":"S Luo","year":"2002","journal-title":"Biochem J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.yexcr.2005.12.006","article-title":"PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway.","volume":"312","author":"DH Yu","year":"2006","journal-title":"Exp Cell Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/adt.2005.3.401","article-title":"A 96-well surrogate survival assay coupled with a special short interfering RNA vector for assessing cancer gene targets with enhanced signal\/noise ratio and its utility in HTS for cancer therapeutic targets.","volume":"3","author":"DH Yu","year":"2005","journal-title":"Assay Drug Dev Technol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2144\/04365ST07","article-title":"One-week 96-well soft agar growth assay for cancer target validation.","volume":"36","author":"N Ke","year":"2004","journal-title":"Biotechniques"},{"key":"ref22","first-page":"435","article-title":"Comprehensive assessment of cell growth properties using an integrated and nonsubjective approach.","volume":"2","author":"G Claassen","year":"2004","journal-title":"Preclinica"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.yexcr.2006.05.001","article-title":"A new inducible RNAi xenograft model for assessing the staged tumor response to mTOR silencing.","volume":"312","author":"N Ke","year":"2006","journal-title":"Exp Cell Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"28476","DOI":"10.1074\/jbc.274.40.28476","article-title":"The endoplasmic reticulum chaperone glycoprotein GRP94 with Ca(2+)-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide-induced apoptosis.","volume":"274","author":"RK Reddy","year":"1999","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1128\/MCB.8.10.4579","article-title":"Identification of highly conserved regulatory domains and protein-binding sites in the promoters of the rat and human genes encoding the stress-inducible 78-kilodalton glucose-regulated protein.","volume":"8","author":"E Resendez Jr","year":"1988","journal-title":"Mol Cell Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"12003","DOI":"10.1016\/S0021-9258(19)50300-3","article-title":"Transactivation of the grp78 promoter by Ca2+ depletion. A comparative analysis with A23187 and the endoplasmic reticulum Ca(2+)-ATPase inhibitor thapsigargin.","volume":"268","author":"WW Li","year":"1993","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.cellbio.21.122303.120200","article-title":"Intracellular signaling by the unfolded protein response.","volume":"22","author":"S Bernales","year":"2006","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"37375","DOI":"10.1074\/jbc.M303619200","article-title":"Induction of Grp78\/BiP by translational block: activation of the Grp78 promoter by ATF4 through and upstream ATF\/CRE site independent of the endoplasmic reticulum stress elements.","volume":"278","author":"S Luo","year":"2003","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/16729","article-title":"Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase.","volume":"397","author":"HP Harding","year":"1999","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1128\/MCB.18.12.7499","article-title":"Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control.","volume":"18","author":"Y Shi","year":"1998","journal-title":"Mol Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S1534-5807(03)00100-X","article-title":"All roads lead to ATF4.","volume":"4","author":"DT Rutkowski","year":"2003","journal-title":"Dev Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2407-5-2","article-title":"Doxorubicin increases the effectiveness of Apo2L\/TRAIL for tumor growth inhibition of prostate cancer xenografts.","volume":"5","author":"A El-Zawahry","year":"2005","journal-title":"BMC Cancer"},{"key":"ref33","first-page":"6201","article-title":"Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy.","volume":"60","author":"K Izuishi","year":"2000","journal-title":"Cancer Res"},{"key":"ref34","first-page":"1408","article-title":"The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.","volume":"58","author":"JM Brown","year":"1998","journal-title":"Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1200\/JCO.1999.17.10.3333","article-title":"American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants.","volume":"17","author":"ML Hensley","year":"1999","journal-title":"J Clin Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0003951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T17:55:10Z","timestamp":1632765310000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0003951"}},"subtitle":[],"editor":[{"given":"Dong-Yan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,12,16]]},"references-count":35,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2008,12,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0003951","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,16]]}}}